African American women who receive primary anth... [J Clin Oncol. 2009] - PubMed

Save items

loading

Related citations in PubMed

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. [J Clin Oncol. 2009]
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, et al. J Clin Oncol. 2009 Jan 10; 27(2):220-6. Epub 2008 Dec 1.
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. [J Natl Cancer Inst. 2012]
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, et al. J Natl Cancer Inst. 2012 Mar 7; 104(5):406-14. Epub 2012 Jan 16.
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients. [Anticancer Drugs. 2008]
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Bao H, Yu D, Wang J, Qiu T, Yang J, Wang L. Anticancer Drugs. 2008 Mar; 19(3):317-23.
Review Triple-negative breast cancer: a short review. [Am J Clin Oncol. 2010]
Review Triple-negative breast cancer: a short review.
Elias AD. Am J Clin Oncol. 2010 Dec; 33(6):637-45.
Review Triple-negative breast cancers: a view from 10,000 feet. [Cancer J. 2010]
Review Triple-negative breast cancers: a view from 10,000 feet.
Ray M, Polite BN. Cancer J. 2010 Jan-Feb; 16(1):17-22.

See reviews... See all...

Cited by 2 PubMed Central articles

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity. [Cancer. 2010]
Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.
Chavez-Macgregor M, Litton J, Chen H, Giordano SH, Hudis CA, Wolff AC, Valero V, Hortobagyi GN, Bondy ML, Gonzalez-Angulo AM. Cancer. 2010 Sep 1; 116(17):4168-77.
Review Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups. [Oncologist. 2010]
Review Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.
Patel TA, Colon-Otero G, Bueno Hume C, Copland JA 3rd, Perez EA. Oncologist. 2010; 15(5):466-75. Epub 2010 Apr 28.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

African American women who receive primary anthracycline- and taxane-based chemo...
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
J Clin Oncol. 2009 Aug 1 ;27(22):e35-7; author reply e38-9. Epub 2009 Jun 29 .

PubMed
Recombinase-mediated cassette exchange provides a versatile platform for gene ta...
Recombinase-mediated cassette exchange provides a versatile platform for gene targeting: knockout of miR-31b.
Genetics. 2009 Sep ;183(1):399-402. Epub 2009 Jun 29 .

PubMed
Development of a type 2 diabetes risk model from a panel of serum biomarkers fro...
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
Diabetes Care. 2009 Jul ;32(7):1207-12.

PubMed
New users of metformin are at low risk of incident cancer: a cohort study among ...
New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.
Diabetes Care. 2009 Sep ;32(9):1620-5. Epub 2009 Jun 29 .

PubMed
Evaluating the capability and cost of a mass influenza and pneumococcal vaccinat...
Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation.
Med Decis Making. 2009 Jul-Aug ;29(4):414-23. Epub 2009 Jun 29 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.

Comment on

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information